F. Ann Millner - 15 May 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
15 May 2025
Net transactions value
-$941,375
Form type
4
Filing time
19 May 2025, 18:51:36 UTC
Previous filing
18 Nov 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Millner F. Ann Director 1600 WEST MERIT PARKWAY, SOUTH JORDAN /s/ Brian G. Lloyd, Attorney-in-Fact 19 May 2025 0001649014

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +2,152 +6.6% $0.000000 34,543 15 May 2025 Direct F1
transaction MMSI Common Stock, No Par Value Options Exercise $1,108,612 +21,250 +62% $52.17 55,793 15 May 2025 Direct F2
transaction MMSI Common Stock, No Par Value Sale $2,049,988 -21,250 -38% $96.47 34,543 15 May 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -13,750 -100% $0.000000 0 15 May 2025 Common Stock 13,750 $52.17 Direct F2, F4
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -7,500 -100% $0.000000 0 15 May 2025 Common Stock 7,500 $52.17 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.
F2 The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.
F3 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.16 to $97.16, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.